Product Images Meclizine Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Meclizine Hydrochloride NDC 59651-808 by Aurobindo Pharma Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 12.5 mg (100 Tablets Bottle) - meclazine fig1

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 12.5 mg (100 Tablets Bottle) - meclazine fig1

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 25 mg (100 Tablets Bottle) - meclazine fig2

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 25 mg (100 Tablets Bottle) - meclazine fig2

This text is a description of a medication called Meclizine Hydrochloride. The medication is in the form of tablets and is distributed by Aurobindo Pharma USA, Inc. Each tablet contains 25 mg of Meclizine, with a dihydrochloride equivalent of 21.07 mg of Meclizine free base. The recommended dosage for vertigo is between 25 mg to 100 mg daily, depending on the clinical response. The medication should be kept in a tightly closed, light-resistant container and stored at a temperature between 20°C to 25°C (68°F to 77°F). The text also mentions the need for child-resistant packaging and provides contact information for the distributor.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 50 mg (100 Tablets Bottle) - meclazine fig3

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 50 mg (100 Tablets Bottle) - meclazine fig3

Chemical Structure - meclazine str

Chemical Structure - meclazine str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.